The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis

被引:30
|
作者
LeBlanc, Jean-Frederic [1 ]
Segal, Jonathan P. [2 ]
de Campos Braz, Lucia Maria [1 ,3 ]
Hart, Ailsa L. [1 ,3 ]
机构
[1] St Marks Hosp, Inflammatory Bowel Dis Unit, Harrow HA1 3UJ, Middx, England
[2] Hillingdon Hosp, Dept Gastroenterol, Uxbridge UB8 3NN, Middx, England
[3] Imperial Coll, Dept Metab Digest & Reprod, Fac Med, London SW7 2AZ, England
关键词
ulcerative colitis; ileoanal pouch inflammatory bowel disease; microbiota; INFLAMMATORY-BOWEL-DISEASE; DOUBLE-BLIND; PROBIOTIC THERAPY; CONTROLLED-TRIAL; INULIN SUPPLEMENTATION; MAINTAINING REMISSION; CLINICAL-PRACTICE; FERMENTED MILK; CROHNS-DISEASE; GUT MICROBIOTA;
D O I
10.3390/nu13061780
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The gut microbiome has been implicated in a range of diseases and there is a rapidly growing understanding of this ecosystem's importance in inflammatory bowel disease. We are yet to identify a single microbe that causes either ulcerative colitis (UC) or pouchitis, however, reduced microbiome diversity is increasingly recognised in active UC. Manipulating the gut microbiome through dietary interventions, prebiotic and probiotic compounds and faecal microbiota transplantation may expand the therapeutic landscape in UC. Specific diets, such as the Mediterranean diet or diet rich in omega-3 fatty acids, may reduce intestinal inflammation or potentially reduce the risk of incident UC. This review summarises our knowledge of gut microbiome therapies in UC and pouchitis.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Risk factors for pouchitis after surgery for ulcerative colitis
    Yamamoto, T.
    COLORECTAL DISEASE, 2013, 15 (06) : 759 - 760
  • [22] Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis
    Bernardi, Francesca
    Fanizzi, Fabrizio
    Parigi, Tommaso Lorenzo
    Zilli, Alessandra
    Allocca, Mariangela
    Furfaro, Federica
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    D'Amico, Ferdinando
    MICROORGANISMS, 2025, 13 (01)
  • [23] CYTOKINE PRODUCTION IN POUCHITIS IS SIMILAR TO THAT IN ULCERATIVE-COLITIS
    PATEL, RT
    BAIN, I
    YOUNGS, D
    KEIGHLEY, MRB
    DISEASES OF THE COLON & RECTUM, 1995, 38 (08) : 831 - 837
  • [24] MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
    Shah, Rajesh
    Shen, Lanlan
    GASTROENTEROLOGY, 2020, 158 (03) : S68 - S68
  • [25] MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
    Shah, Rajesh
    Shen, Lanlan
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S41 - S42
  • [26] Clinical features and management of pouchitis in Japanese ulcerative colitis patients
    Motoi Uchino
    Hiroki Ikeuchi
    Hiroki Matsuoka
    Toshihiro Bando
    Yoshio Takesue
    Naohiro Tomita
    Surgery Today, 2013, 43 : 1049 - 1057
  • [27] Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients
    Ikeuchi, H
    Nakano, H
    Uchino, M
    Nakamura, M
    Yanagi, H
    Noda, M
    Yamamura, T
    DIGESTIVE SURGERY, 2004, 21 (03) : 197 - 201
  • [28] Review article: treatment of mild to moderate ulcerative colitis and pouchitis
    Gionchetti, P
    Amadini, C
    Rizzello, F
    Venturi, A
    Campieri, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 : 13 - 19
  • [29] Alterations in the Fungal Microbiome in Ulcerative Colitis
    Hsia, Katie
    Zhao, Naisi
    Chung, Mei
    Algarrahi, Khalid
    Kouhsari, Laleh Montaser
    Fu, May
    Chen, Hannah
    Singh, Siddharth
    Michaud, Dominique S.
    Jangi, Sushrut
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (10) : 1613 - 1621
  • [30] Colectomy risk score predicts pouchitis in patients with ulcerative colitis
    Ikebata, Akiyoshi
    Okabayashi, Koji
    Tsuruta, Masashi
    Shigeta, Kohei
    Seishima, Ryo
    Shimoda, Masayuki
    Naganuma, Makoto
    Kitagawa, Yuko
    UPDATES IN SURGERY, 2022, 74 (02) : 649 - 655